Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Has your distributor discontinued their kits and chromogenic substrates? Haven't found the right product line? Aniara Diagnostica has them available!!


News provided by

Aniara Diagnostica

Oct 13, 2022, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Aniara Diagnostica is pleased to announce the availability of Thrombin and Factor Xa assays as well as various Chromogenic Substrates for quality control (QC testing)

WEST CHESTER, Ohio, Oct. 13, 2022 /PRNewswire-PRWeb/ -- Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today's highest standards for product quality and cost-efficient delivery.

For Research Use Only. Not for Use in Diagnostic Procedures.

The entire Aniara line is available for purchase at http://www.aniara.com.

Post this

Specific kits are USP/EP compliant for Quality Control testing.
USP/EP Compliant Heparin QC Kits Chromogenic Anti-IIa and Anti-Xa methods are used for measuring homogeneous Heparin for Quality Control.

BIOPHEN Heparin Anti-IIa (2 stages) A220005 click here for more information
BIOPHEN Heparin Anti-Xa (2 stages) A221005 click here for more information

Heparin Anti-IIa (Kinetics) BIOPHEN™ Heparin Anti-IIa (Kinetics) is a method for measuring Heparin in purified systems.

BIOPHEN Heparin Anti-IIa (kinetics) A221020 click here for more information

Chromogenic Substrates: Thrombin Chromogenic Substrates for use in the Anti-IIa assay for Quality Control.
BIOPHEN™ CS-01(38) Thrombin (1 x 25mg) A229001 click here for more information
BIOPHEN™ CS-01(38) Thrombin (12 x 25mg) A229001C click here for more information

Chromogenic Substrates: Factor Xa Factor Xa Chromogenic Substrates for use in the Anti-Xa assay for Quality Control.

BIOPHEN™ CS-11(22) Factor Xa (1x25mg) A229015 click here for more information
BIOPHEN™ CS-11(65) Factor Xa (1 x 25mg) A229014 click here for more information
BIOPHEN™ CS-11(65) Factor Xa (12 x 25mg) A229014C click here for more information
BIOPHEN™ CS-11(32) Factor Xa Chromogenic substrate A229011 click here for more information

BIOPHEN™ CS-21(66) Activated Protein C Chromogenic Substrate A229021 click here for more information
BIOPHEN™ CS-41(03) Plasmin and Plasminogen-SK Chromogenic substrate A229041click here for more information

Purified Human Protein: Anti-Thrombin (AT) Human Anti-Thrombin for Quality Control including studies on Heparin and other glycoaminoglycans (GAGs).

Anti-Thrombin (AT) (1 x 1.5 mg) APP004B click here for more information
Anti-Thrombin (AT) (10 x 1.5 mg) APP004L click here for more information
Anti-Thrombin (AT) (1 x 3.75 mg) APP004D click here for more information
Anti-Thrombin (AT) (10 x 3.75 mg) APP004M click here for more information
Anti-Thrombin (AT) (1 x 10 mg) APP004C click here for more information

Purified Human Protein: Thrombin Purified Human α-Thrombin for use in Anti-IIa assays for Quality Control.

Human Thrombin 1 x 10 NIH AEZ006O click here for more information
Human Thrombin 6 x 10 NIH AEZ006K click here for more information
Human Thrombin 1 x 100 NIH AEZ006A click here for more information
Human Thrombin 10 x 100 NIH AEZ006L click here for more information
Human Thrombin 1 x 1000 NIH AEZ006B click here for more information

Purified Bovine Enzyme: Factor Xa Purified Bovine Factor Xa for use in Anti-Xa assays for Quality Control of Heparin and other glycoaminoglycans (GAGs).

Purified Bovine Factor Xa (1 x 30 µg) ABE101D click here for more information
Purified Bovine Factor Xa (10 x 30 µg) ABE101L click here for more information

Buffers Used for USP/EP Heparin QC Assays Buffers for use in the Anti-IIa and Anti-Xa quality control assays are compliant with US and European Pharmacopeia monographs.

USP Heparin BSA Buffer without PEG (1L) – pH 8.4 A12-0017 click here for more information
USP Anti-Factor Xa Activity Buffer (1L) – pH 8.4 A12-0018 click here for more information
Tris-NaCI Buffer, with Albumin - (pH 7.4) AAR005L click here for more information
Tris-NaCI Buffer - (pH 7.4) AAR028K click here for more information
Tris EDTA NaCI Buffer -( pH 8.4) AAR029K click here for more information
Tris NaCI EDTA PEG Buffer - (pH 8.4) AAR030K click here for more information
Tris NaCI EDTA BSA buffer - (pH 8.4) AAR031K click here for more information

Click the link to see a competitor comparison
Literature (aniara.com)

The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.

Media Contact

Maria Waldron, Aniara Diagnostica, 513-342-3018, [email protected]

SOURCE Aniara Diagnostica

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.